As every year, World Cancer Day is commemorated on February 4. One of the greatest challenges of modern medicine is finding reliable diagnoses and effective treatments for the different types of cance...
Read more
A study by IDIBELL, ICO and IARC has linked the levels of certain inflammatory molecules with mortality in breast cancer patients.
Read more
This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential eligibility for bisphosphonate treatment.
Read more
Multidisciplinary experts will conduct a thorough analysis of national cancer plans and design innovative interventions that will be tailored to specific regions.
Read more
The research, led by experts in cancer epidemiology from the Biosanitary Research Institute ibs.GRANADA, analyzed exposure to 16 heavy metals and semimetals in 578 women from four Spanish provinces.
Read more
The new study, led by Eva González-Suárez, head of the Transformation and Metastase Group at the Spanish National Cancer Research Centre (CNIO), describes the behaviour and interaction of these two ...
Read more
It has been shown that the therapy endocrine, combined with a drug used in breast cancer called Abemaciclib, means a treatment with greater safety and better results perceived by patients in the treat...
Read more
A study led by researchers from the Nutrition and Cancer Unit of the Catalan Institute of Oncology and the Biomedical Research Institute of Bellvitge (IDIBELL), published in the scientific journal ...
Read more
The University of Barcelona is leading a European project to clinically validate an Artificial Intelligence solution to predict the specific response of each patient in breast cancer chemotherapy.
Read more
Researchers from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO)-IDIBELL and the Vall d’Hebron Institute of Oncology (VHIO), which forms part of the Vall d’Hebron Campus, par...
Read more
Among the many studies that counted on the participation of VHIO researchers and clinical investigators at VHIO as first and/or co-authors were several clinical trials developed by the SOLTI academic ...
Read more
The high number of immune cells within tumors is an indicator of a good prognosis, since they attack the tumor and help destroy it.
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The results show that adenocarcinoma exhibits much more active and fun...
